Baird Maintains a 'Neutral' on Dendreon (DNDN); Lowering Estimates & PT

September 2, 2011 10:15 AM EDT
Get Alerts DNDN Hot Sheet
Price: $0.13 --0%

Rating Summary:
    2 Buy, 15 Hold, 9 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Baird maintains a 'Neutral' on Dendreon (NASDAQ: DNDN), price target lowered to $14.00.

Baird analyst says, "Lowering Provenge estimates and price target following less-than-stellar feedback from a large, recent oncologist survey. Despite DNDN's increasing emphasis on urologists, oncologists remain an important constituency with meaningful insight into demand post-capacity scale-up as well as competitive dynamics. When guidance was reset last month, we speculated longer-term demand-related issues may be at work. Feedback we highlight herein does little to assuage that concern. Remain more comfortable on the sidelines."

"We now model $66M, $78M and $391M for Q311, Q411 and FY12, respectively."

For more ratings news on Dendreon click here and for the rating history of Dendreon click here.

Shares of Dendreon closed at $11.89 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Robert W Baird